Found: 5
Select item for more details and to access through your institution.
Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 6050, doi. 10.3390/ijms23116050
- By:
- Publication type:
- Article
A How to Guide: Clinical Population Test Development and Authorization of MALDI-ToF Mass Spectrometry-Based Screening Tests for Viral Infections.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 9, p. 1958, doi. 10.3390/v14091958
- By:
- Publication type:
- Article
Validation of a MALDI-TOF MS Method for SARS-CoV-2 Detection on the Bruker Biotyper and Nasopharyngeal Swabs: A Brazil—UK Collaborative Study.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 8, p. 1470, doi. 10.3390/diagnostics13081470
- By:
- Publication type:
- Article
Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 10, p. 2521, doi. 10.3390/diagnostics12102521
- By:
- Publication type:
- Article
Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 10, p. 746, doi. 10.3390/diagnostics10100746
- By:
- Publication type:
- Article